Thoratec Corp (NASDAQ:THOR)

CAPS Rating: 3 out of 5

The Company manufactures, develops and markets medical devices used for circulatory support.

Results 1 - 19 of 19

Recs

0
Member Avatar TerryHoodSr (62.62) Submitted: 4/21/2014 10:46:25 AM : Outperform Start Price: $33.99 THOR Score: -25.84

long term buy at $33, 1yr target $45, 5yr EPS growth 27%

Recs

0
Member Avatar TexasSue (< 20) Submitted: 12/29/2013 1:31:20 AM : Underperform Start Price: $36.13 THOR Score: +32.78

Thoratec Heartmate II devices say an increase in pump clots and death. Initial FDA reports were of clotting in about 1.2% .. which was true for a while.. during 2012 - for some unknown reasons the clot rate has shot up to 9% or higher depending on who's numbers you use. FDA investigation to pursue I would say.. and there are already class action lawsuits being filed due to the deaths.

Recs

0
Member Avatar stockron (< 20) Submitted: 12/29/2010 11:20:35 PM : Outperform Start Price: $28.61 THOR Score: -62.22

Cheap

Recs

0
Member Avatar Melchidael (< 20) Submitted: 7/1/2010 3:33:43 PM : Outperform Start Price: $42.42 THOR Score: -125.94

THOR has just recently been approved to market the Heartmate ll pump for destination cardiac patients. This allows hope for many thousands of cardiac patients who might have less than a year to live and who are not elgible for or waiting for a transplant.

Recs

0
Member Avatar dutchredneck (81.99) Submitted: 9/23/2009 10:30:55 AM : Outperform Start Price: $30.48 THOR Score: -94.62

Solid growth company will outperform the S&P

Recs

0
Member Avatar BfloBull (82.80) Submitted: 1/28/2009 10:49:58 AM : Outperform Start Price: $31.79 THOR Score: -144.52

LT Growth: 24%

EPS Surp: Pos last 2 qtrs

MF: +

Large Volume Increae

Insight, Driehaus, Fid Contra, Veredus, Calamos, Lord Abbett,

Emerald, Kopp, NCM

=BUY!

Recs

0
Member Avatar bigchuck27 (< 20) Submitted: 1/19/2009 11:09:34 AM : Outperform Start Price: $30.06 THOR Score: -146.25

solid

Recs

0
Member Avatar rklapman (84.16) Submitted: 12/15/2008 8:40:27 PM : Outperform Start Price: $28.00 THOR Score: -130.95

Expect takeover by MDT

Recs

0
Member Avatar WilliamCrook2007 (< 20) Submitted: 11/20/2008 2:33:00 PM : Outperform Start Price: $20.34 THOR Score: -121.12

IBD

Recs

0
Member Avatar bigchuck28 (63.90) Submitted: 11/18/2008 11:45:34 PM : Outperform Start Price: $22.21 THOR Score: -112.95

Strong fundamentals.

Recs

0
Member Avatar oneheart329 (33.87) Submitted: 10/31/2008 9:36:42 PM : Outperform Start Price: $24.61 THOR Score: -98.34

another strong biotech company thats well run

Recs

0
Member Avatar blackmink18 (< 20) Submitted: 10/8/2008 11:29:57 PM : Outperform Start Price: $24.13 THOR Score: -90.62

People will have bad hearts. Thanks McDonalds

Recs

0
Member Avatar stockguy07 (< 20) Submitted: 8/27/2008 12:11:01 AM : Outperform Start Price: $25.22 THOR Score: -52.70

highlighted in IBD Tech. says way ahead of competition in heart pumps. sounds interesting.

Recs

0
Member Avatar pytheian (31.48) Submitted: 4/22/2008 6:28:51 PM : Underperform Start Price: $15.72 THOR Score: -20.46

This company is a lottery ticket but it's priced like the drawing is already complete. Institutions disposed 3% of their holdings last quarter; insiders acquiring (non open market) and doing same. Why bother with this?

Recs

0
Member Avatar Thieving (< 20) Submitted: 10/8/2007 7:24:09 PM : Outperform Start Price: $20.86 THOR Score: -5.00

Long term play on aging population.

Recs

0
Member Avatar mdinvestor (< 20) Submitted: 1/28/2007 10:27:09 PM : Outperform Start Price: $17.79 THOR Score: +2.42

Increasing medicare coverage that will allow more hospitals to implant the device, improved new product on the verge of approval, best in class.

Recs

0
Member Avatar kendall43 (< 20) Submitted: 12/8/2006 1:12:51 PM : Outperform Start Price: $15.45 THOR Score: +23.79

well managed; great performer over past few years

Recs

0
Member Avatar pushpen1 (98.72) Submitted: 11/1/2006 2:35:39 PM : Outperform Start Price: $15.23 THOR Score: +22.48

BTT and DT market have tremendous potential. Will shoot up probably beginning July 2007. Strong potential for a takeover by another company. WIll see $50+ by the end of 2007, if not taken over earlier at a hefty premium.

Recs

0
Member Avatar lmiller512 (< 20) Submitted: 8/24/2006 10:38:23 PM : Outperform Start Price: $15.08 THOR Score: +14.01

Totally robotic heart implant FDA approved. new model in testing,should be approved by year end

Results 1 - 19 of 19

Featured Broker Partners


Advertisement